Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,073
Closed -$23.7K 2865
2023
Q2
$23.7K Buy
+32,073
New +$29.8K ﹤0.01% 2517
2022
Q3
Sell
-62,084
Closed -$218K 3297
2022
Q2
$218K Sell
62,084
-2,950
-5% -$11K ﹤0.01% 2842
2022
Q1
$328K Buy
65,034
+308
+0.5% +$1.56K ﹤0.01% 2695
2021
Q4
$407K Buy
64,726
+4,530
+8% +$30.9K ﹤0.01% 2593
2021
Q3
$479K Sell
60,196
-1,274
-2% -$10.5K ﹤0.01% 2273
2021
Q2
$461K Buy
61,470
+4,735
+8% +$33.1K ﹤0.01% 2238
2021
Q1
$343K Sell
56,735
-6,656
-10% -$51.2K ﹤0.01% 2216
2020
Q4
$362K Buy
+63,391
New +$403K ﹤0.01% 2439

Other funds holding VXRT

HSBC Holdings's VXRT Position: Q3 2023 in Review

HSBC Holdings sold out of Vaxart (VXRT) in Q3 2023, closing a stake of 32,073 shares — an estimated $23.7K sold.

HSBC Holdings first reported a position in VXRT in Q4 2020 and held it in 8 quarters. The position peaked at $479K in Q3 2021. 96 funds tracked by Wall St. Rank hold VXRT as of Q3 2023.

  • HSBC Holdings reported no remaining Vaxart position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 32,073 Vaxart shares in Q3 2023, an estimated $23.7K.
  • HSBC Holdings first reported a position in Vaxart in Q4 2020 and held it in 8 quarters.
  • HSBC Holdings's Vaxart position peaked at $479K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Vaxart as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.